Live Nasdaq Composite: Markets Pivot From Headlines to Q2 Earnings, Chip Stock Momentum

Health and Healthcare

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

1320 Articles

Jon C. Ogg | Sep 1, 2020 at 8:46 AM EDT

3 COVID-19 Vaccine Trials Are Now in Phase 3, With More on the Way

Three U.S. COVID-19 vaccine trials are now in Phase 3 studies. All three appear to have some serious benefits, but…

Chris Lange | Aug 19, 2020 at 11:33 AM EDT

Johnson & Johnson’s Newest Multibillion Dollar Acquisition

After Momenta Pharmaceuticals announced that it would be acquired by pharmaceutical giant Johnson & Johnson, the biotechnology company's shares soared…

Chris Lange | Jul 30, 2020 at 11:54 AM EDT

Johnson & Johnson Takes the Next Big Step in Fighting COVID-19

Johnson & Johnson has announced that it will launch its human study for its lead vaccine candidate in the United…

Jon C. Ogg | Jul 28, 2020 at 1:42 PM EDT

Beyond COVID-19, Credit Suisse Shows Its Top Health Care Recovery Stock Picks

Credit Suisse has assembled its favorite health care recovery stocks for a recovering base of elective surgeries and for the…

Lee Jackson | Jul 23, 2020 at 7:36 AM EDT

Stock Dividend Yields the Highest Versus Bonds Since 1955: 5 to Buy Now for Income

If you are a bond and income investor now, times are grim. One analyst says that the best income portfolio…

Jon C. Ogg | Jul 20, 2020 at 12:32 PM EDT

8 Blue Chip Stocks to Buy Ahead of Earnings for Big Upside

Many investors feel like the key stocks in the market have simply gotten away from them, but those fears are…

Jon C. Ogg | Jul 20, 2020 at 9:09 AM EDT

Top Analyst Upgrades and Downgrades: AMD, Amgen, Dropbox, EOG, Gilead, J&J, Microsoft, Newmont, Starbucks, Valero and More

Stocks were looking for direction on Monday ahead of this week’s earnings deluge. With an election coming up and with…

Chris Lange | Jul 16, 2020 at 10:57 AM EDT

Johnson & Johnson’s Impressive Quarter, Still Held Back by One Segment

Johnson & Johnson released better than expected quarterly results and guidance before the markets opened on Thursday.

Chris Lange | Jul 12, 2020 at 7:05 AM EDT

Delta Air, Johnson & Johnson, Netflix, Pepsi and More Major Earnings This Week

Here, 24/7 Wall St. offers a preview of what to expect from Delta Air Lines, Netflix, PepsiCo and some of…

Chris Lange | Jun 10, 2020 at 11:18 AM EDT

Johnson & Johnson Accelerates Its COVID-19 Vaccine Hopes

Johnson & Johnson has announced that it will accelerate initiation of its early stage first-in-human clinical trial for the treatment…

Lee Jackson | May 20, 2020 at 7:26 AM EDT

5 Dividend Aristocrat Stocks to Buy That Could Weather Another Brutal Sell-Off

These five very conservative Dividend Aristocrat stocks may offer nervous investors some shelter from the storm if markets head south…

Jon C. Ogg | May 8, 2020 at 7:32 AM EDT

20 Bold Companies Raising Dividends Right Into the Recession

Here are 20 bold companies that have defied the odds by raising their dividends, after already knowing they were facing…

Lee Jackson | Apr 30, 2020 at 7:39 AM EDT

5 Stocks to Buy Now for a W-Shaped Recovery With a Long Recession

These five stocks could be big winners if the recovery is W-shaped and we and we return to the March…

Jon C. Ogg | Apr 30, 2020 at 6:55 AM EDT

15 Strong Stocks With Rising Dividends Despite the Recession

Even in the toughest times, some companies still manage to generate dividend growth and prove that they have safe dividends.…

Jon C. Ogg | Apr 28, 2020 at 9:02 AM EDT

Top Analyst Upgrades and Downgrades: AT&T, Cognex, Disney, J&J, Keurig Dr Pepper, PayPal, Roku, Shopify, Square, Valero and More

Tuesday's top analyst upgrades and downgrades included AT&T, Cognex, Johnson & Johnson, Keurig Dr Pepper, PayPal, Roku, Shopify, Square, Valero…

1 … 32 33 34 35 36 … 89

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

3 COVID-19 Vaccine Trials Are Now in Phase 3, With More on the Way

Johnson & Johnson’s Newest Multibillion Dollar Acquisition

Johnson & Johnson Takes the Next Big Step in Fighting COVID-19

Beyond COVID-19, Credit Suisse Shows Its Top Health Care Recovery Stock Picks

Stock Dividend Yields the Highest Versus Bonds Since 1955: 5 to Buy Now for Income

8 Blue Chip Stocks to Buy Ahead of Earnings for Big Upside

Top Analyst Upgrades and Downgrades: AMD, Amgen, Dropbox, EOG, Gilead, J&J, Microsoft, Newmont, Starbucks, Valero and More

Johnson & Johnson’s Impressive Quarter, Still Held Back by One Segment

Delta Air, Johnson & Johnson, Netflix, Pepsi and More Major Earnings This Week

Johnson & Johnson Accelerates Its COVID-19 Vaccine Hopes

5 Dividend Aristocrat Stocks to Buy That Could Weather Another Brutal Sell-Off

20 Bold Companies Raising Dividends Right Into the Recession

5 Stocks to Buy Now for a W-Shaped Recovery With a Long Recession

15 Strong Stocks With Rising Dividends Despite the Recession

Top Analyst Upgrades and Downgrades: AT&T, Cognex, Disney, J&J, Keurig Dr Pepper, PayPal, Roku, Shopify, Square, Valero and More

Live Nasdaq Composite: Markets Pivot From Headlines to Q2 Earnings, Chip Stock Momentum

If You Have Only $10,000, Invest in These 3 Dividend ETFs by August

She Converted $25,000 to a Roth to Cut Future Taxes. It Cost Her the Senior Property-Tax Freeze, and Her Medicare Premium Could Be Next.

Forget ETHA. iShares’ Other Ether Fund Is Nearly Identical, Except It Pays You

She Converted $25,000 to a Roth to Cut Future Taxes. It Cost Her the Senior Property-Tax Freeze, and Her Medicare Premium Could Be Next.

He Cashed Out His Bitcoin at 68 to Play It Safe. Medicare Read It as a Six-Figure Raise.

If You Have Only $10,000, Invest in These 3 Dividend ETFs by August

She Converted $25,000 to a Roth to Cut Future Taxes. It Cost Her the Senior Property-Tax Freeze, and Her Medicare Premium Could Be Next.

Johnson & Johnson : JNJ

All Johnson & Johnson Articles

3 COVID-19 Vaccine Trials Are Now in Phase 3, With More on the Way

Johnson & Johnson’s Newest Multibillion Dollar Acquisition

Johnson & Johnson Takes the Next Big Step in Fighting COVID-19

Beyond COVID-19, Credit Suisse Shows Its Top Health Care Recovery Stock Picks

Stock Dividend Yields the Highest Versus Bonds Since 1955: 5 to Buy Now for Income

8 Blue Chip Stocks to Buy Ahead of Earnings for Big Upside

Top Analyst Upgrades and Downgrades: AMD, Amgen, Dropbox, EOG, Gilead, J&J, Microsoft, Newmont, Starbucks, Valero and More

Johnson & Johnson’s Impressive Quarter, Still Held Back by One Segment

Delta Air, Johnson & Johnson, Netflix, Pepsi and More Major Earnings This Week

Johnson & Johnson Accelerates Its COVID-19 Vaccine Hopes

5 Dividend Aristocrat Stocks to Buy That Could Weather Another Brutal Sell-Off

20 Bold Companies Raising Dividends Right Into the Recession

5 Stocks to Buy Now for a W-Shaped Recovery With a Long Recession

15 Strong Stocks With Rising Dividends Despite the Recession

Top Analyst Upgrades and Downgrades: AT&T, Cognex, Disney, J&J, Keurig Dr Pepper, PayPal, Roku, Shopify, Square, Valero and More

Live Nasdaq Composite: Markets Pivot From Headlines to Q2 Earnings, Chip Stock Momentum

If You Have Only $10,000, Invest in These 3 Dividend ETFs by August

She Converted $25,000 to a Roth to Cut Future Taxes. It Cost Her the Senior Property-Tax Freeze, and Her Medicare Premium Could Be Next.

Forget ETHA. iShares’ Other Ether Fund Is Nearly Identical, Except It Pays You

Featured Reads

She Converted $25,000 to a Roth to Cut Future Taxes. It Cost Her the Senior Property-Tax Freeze, and Her Medicare Premium Could Be Next.

He Cashed Out His Bitcoin at 68 to Play It Safe. Medicare Read It as a Six-Figure Raise.